西班牙高危目标人群和医护人员的流感疫苗接种率及2017至2020年的变化
基于2020年西班牙欧洲健康调查(2019年7月至2020年7月)的横断面研究显示,≥65岁人群流感疫苗接种率为54.4%,高风险慢性病人群为41.6%,医护人员为26.53%;除癌症患者接种率从33.2%升至46.1%(p<0.001)外,各目标人群自2017年以来无显著改善。
要点
- ≥65岁人群接种率54.4%,高风险慢性病人群41.6%,医护人员26.53%。
- 癌症患者接种率从2017年33.2%升至2020年46.1%(p<0.001),其余目标人群无显著改善。
- 女性、≥35岁、西班牙出生、自报呼吸或心血管疾病、糖尿病、癌症及医护人员身份与接种概率升高显著相关。
核心结论
- 西班牙目标人群流感疫苗接种率低于理想水平,且自2017年以来无显著改善。
- 高龄、女性、西班牙出生是疫苗接种的正向预测因素。
- COVID-19大流行凸显了实施新策略以提高流感疫苗接种率的紧迫需要。
研究设计与样本
- 横断面研究,使用2020年西班牙欧洲健康调查(EHSS2020)数据,调查时间为2019年7月至2020年7月。
- 研究对象为≥15岁参与者共22,072人,分析变量包括性别、年龄、出生国家、医护人员身份及自报呼吸系统疾病、心血管疾病、糖尿病、癌症和脑血管疾病。
- 主要研究变量为自报过去一年流感疫苗接种情况,采用多变量logistic回归评估时间变化及与接种相关的变量。
主要发现
- ≥15岁参与者总接种率为19.2%。
- ≥65岁人群接种率为54.4%,高风险慢性病人群为41.6%,医护人员为26.53%。
- 按疾病分接种率:脑血管疾病52.1%,心血管疾病51.3%,糖尿病48.3%,癌症46.1%,呼吸系统疾病36.2%。
- 除癌症患者接种率从2017年33.2%升至2020年46.1%(p<0.001)外,其余目标人群自2017年以来无显著改善。
- 女性、年龄≥35岁、西班牙出生、自报呼吸或心血管疾病、糖尿病、癌症及医护人员身份与接种概率升高显著相关。
临床怎么用
- 作者认为高龄、女性和西班牙出生是疫苗接种的正向预测因素。
- 作者指出COVID-19大流行凸显了实施新策略以提高流感疫苗接种率的紧迫需要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Using the 2020 European Health Survey for Spain (EHSS2020), which ran from July 2019 to July 2020, we aimed to describe influenza vaccination uptake among the following target groups; individuals aged ≥65 years, health care workers (HCWs), and persons with high-risk chronic medical conditions. We analyzed changes in uptake since the previous Spanish National Health Interview Survey conducted in 2017 and identified variables associated with vaccine uptake. METHODS: We performed a cross-sectional study. The primary study variable was the self-reported uptake of influenza vaccine in the previous year. We analyzed sex, age, country of birth, and being an HCW. We identified participants with self-reported respiratory diseases, cardiovascular disease, diabetes, cancer, and cerebrovascular diseases. Multivariable logistic regression was applied to assess changes over time and to identify variables associated with vaccination in target groups. RESULTS: Uptake was 19.2% in 22,072 participants aged ≥15 years. Uptake was 54.4% for those aged ≥65 years, 41.6% for those with a high-risk medical condition, and 26.53% among HCWs. Uptake by disease was 52.1% for cerebrovascular diseases, 51.3% for cardiovascular diseases, 48.3% for diabetes, 46.1% for cancer, and 36.2% for respiratory diseases. No significant improvement has been observed since 2017 in any target group, except for participants with cancer, whose uptake increased from 33.2% to 46.1%(p < 0.001). The variables that significantly increased the probability of reporting vaccine uptake were female sex, age ≥35 years, being born in Spain, self-reported respiratory or cardiovascular diseases, diabetes, cancer, and being a HCW. CONCLUSIONS: Influenza vaccination uptake among target groups in Spain is below desirable levels and has not improved significantly since 2017. Older age, female sex, and being born in Spain are positive predictors of vaccine uptake. The COVID-19 pandemic highlights the urgent need to implement new strategies to increase influenza vaccine uptake.
引用
- Sanz-Rojo S, Jiménez-García R, López-de-Andrés A, et al. Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020. Vaccine. 2021. PMID: 34742593. doi:10.1016/j.vaccine.2021.10.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。